Researchmoz added Most up-to-date research on "Global Diabetic Therapeutic Market 2017-2021" to its huge collection of research reports.
The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
Technavios analysts forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021.
Request Sample Copy of Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=964359
Covered in this report
The report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period..
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Global Diabetic Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Other prominent vendors
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
Amgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Aurobindo Pharma
Baxalta
Belrose Pharma
BHV Pharma
Biocon
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
Bristol-Myers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Chipscreen Biosciences
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
ConjuChem
CureDM
CymaBay Therapeutics
Daewoong
Daiichi Sankyo
Dance Biopharm
DiaMedica
Diamyd Therapeutics
Diasome Pharmaceuticals
DiaVacs
Dong-A ST
Eisai
Elcelyx Therapeutics
Esperion Therapeutics
Exsulin
F. Hoffmann-La Roche
Gan & Lee Pharmaceuticals
Generex Biotechnology
Genfit
GlaxoSmithKline
HanAll BioPharma
Hanmi Pharmaceutical
Hua Medicine
Iltoo Pharma
Intarcia Therapeutics
InteKrin Therapeutics
Intrexon
Ionis Pharmaceuticals
Islet Sciences
ISU Abxis
Janssen Pharmaceuticals
Japan Tobacco
JCR Pharmaceuticals
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kamada
KinDex Pharmaceuticals
Kissei
Kotobuki
Kowa Company
Laboratoires SMB
Lexicon Pharmaceuticals
Ligand Pharmaceuticals
Living Cell Technologies
Livzon
LIXTE Biotechnology
Lupin
MacroGenics
Madrigal Pharmaceuticals
MannKind Corporation
MedImmune
Melior Pharmaceuticals
Merrion Pharmaceuticals
Merz Pharmaceuticals
Metabolic Solutions Development
Mitsubishi Tanabe Pharma
Mylan
Neothetics
Neuraltus Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Novartis
NuSirt Biopharma
Oramed
Orexigen Therapeutics
Osiris Therapeutics
Peptron
Perle Biosciences
Pfizer
PhaseBio Pharmaceuticals
Poxel
Protalix BioTherapeutics
Raptor
Recordati
Regeneron Pharmaceuticals
REGENX BioSciences
REGiMMUNE
Rhythm Pharmaceuticals
Saniona
Santaris Pharma
Sanwa Kagaku Kenkyusho
Serometrix
Shionogi
Shire
Sigma-Tau
Sirona Biochem
Strongbridge Biopharma
Sun Pharma
Takeda Pharmaceuticals
Teva
Thera Technologies
Theracos
Toleranzia
Tolerion
Torrent Pharmaceuticals
Transition Therapeutics
UCB
Utrecht Holdings
VeroScience
Vivus
vTv Therapeutics
XBiotech
Xeris Pharmaceuticals
XOMA
Zafgen
Zydus Cadila
Market driver
Change in patient preference
For a full, detailed list, view our report
Market challenge
Complex storage conditions and distribution policies for insulin
For a full, detailed list, view our report
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-diabetic-therapeutic-market-2017-2021-report.html/toc
Market trend
Focus on oral insulin therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.
Technavios analysts forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021.
Request Sample Copy of Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=964359
Covered in this report
The report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period..
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Global Diabetic Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Other prominent vendors
AbbVie
Actelion Pharmaceuticals
Adocia
Aegerion Pharmaceuticals
Akros Pharma
Alnylam Pharmaceuticals
Amarin
Amgen
Amicus Therapeutics
Arbutus Biopharma
Arena Pharmaceuticals
Astellas Pharma
Atheronova
Aurobindo Pharma
Baxalta
Belrose Pharma
BHV Pharma
Biocon
Biodel
BioMarin
Bionaturis
Biosidus
Biospherics
Boehringer Ingelheim
Bristol-Myers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Chipscreen Biosciences
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
ConjuChem
CureDM
CymaBay Therapeutics
Daewoong
Daiichi Sankyo
Dance Biopharm
DiaMedica
Diamyd Therapeutics
Diasome Pharmaceuticals
DiaVacs
Dong-A ST
Eisai
Elcelyx Therapeutics
Esperion Therapeutics
Exsulin
F. Hoffmann-La Roche
Gan & Lee Pharmaceuticals
Generex Biotechnology
Genfit
GlaxoSmithKline
HanAll BioPharma
Hanmi Pharmaceutical
Hua Medicine
Iltoo Pharma
Intarcia Therapeutics
InteKrin Therapeutics
Intrexon
Ionis Pharmaceuticals
Islet Sciences
ISU Abxis
Janssen Pharmaceuticals
Japan Tobacco
JCR Pharmaceuticals
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kamada
KinDex Pharmaceuticals
Kissei
Kotobuki
Kowa Company
Laboratoires SMB
Lexicon Pharmaceuticals
Ligand Pharmaceuticals
Living Cell Technologies
Livzon
LIXTE Biotechnology
Lupin
MacroGenics
Madrigal Pharmaceuticals
MannKind Corporation
MedImmune
Melior Pharmaceuticals
Merrion Pharmaceuticals
Merz Pharmaceuticals
Metabolic Solutions Development
Mitsubishi Tanabe Pharma
Mylan
Neothetics
Neuraltus Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Novartis
NuSirt Biopharma
Oramed
Orexigen Therapeutics
Osiris Therapeutics
Peptron
Perle Biosciences
Pfizer
PhaseBio Pharmaceuticals
Poxel
Protalix BioTherapeutics
Raptor
Recordati
Regeneron Pharmaceuticals
REGENX BioSciences
REGiMMUNE
Rhythm Pharmaceuticals
Saniona
Santaris Pharma
Sanwa Kagaku Kenkyusho
Serometrix
Shionogi
Shire
Sigma-Tau
Sirona Biochem
Strongbridge Biopharma
Sun Pharma
Takeda Pharmaceuticals
Teva
Thera Technologies
Theracos
Toleranzia
Tolerion
Torrent Pharmaceuticals
Transition Therapeutics
UCB
Utrecht Holdings
VeroScience
Vivus
vTv Therapeutics
XBiotech
Xeris Pharmaceuticals
XOMA
Zafgen
Zydus Cadila
Market driver
Change in patient preference
For a full, detailed list, view our report
Market challenge
Complex storage conditions and distribution policies for insulin
For a full, detailed list, view our report
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-diabetic-therapeutic-market-2017-2021-report.html/toc
Market trend
Focus on oral insulin therapies
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment